Search

Your search keyword '"Pijoan, José Ignacio"' showing total 17 results
Start Over Author "Pijoan, José Ignacio" Search Limiters Full Text
17 results on '"Pijoan, José Ignacio"'

1. Infarto de miocardio con elevación del segmento ST revascularizado. Tendencias temporales de los tratamientos contemporáneos y su impacto en los resultados

Author

Ribera, Aida, Marsal, Josep R., Faixedas, María T., Rosas, Alba, Tizón-Marcos, Helena, Rojas, Sergio, Labata, Carlos, Cárdenas, Mérida, Homs, Silvia, Tomás-Querol, Carlos, García-Picart, Joan, Roura, Gerard, Masotti, Mónica, Mauri, Josepa, Pijoan, José Ignacio, Barrabés, José A., and Ferreira-González, Ignacio

Published
2022
Full Text
View/download PDF

2. Mapping the Patient-Oriented Prostate Utility Scale From the Expanded Prostate Cancer Index Composite and the Short-Form Health Surveys

Author

Ferrer, Montse, Pont, Àngels, Garin, Olatz, Pardo, Yolanda, Zamora, Víctor, Gutiérrez, Cristina, Ventura, Montse, Guedea, Ferran, Ferrer, Ferran, Boladeras, Ana, Slocker, Andrea, Suárez, José Francisco, Castells, Manuel, Bonet, Xavier, Cabrera, Patricia, Delgado, David B., Ortiz, M<ce:sup loc='post">a</ce:sup>José, Herruzo, Ismael, López-Torrecilla, José, Pastor, Jorge, Muñoz, Víctor, Willsich, Patricia, Vázquez, Marisa, Roselló, Àlvar, Eraso, Arantxa, Ferrer, Carlos, Sánchez, Ángel, Gómez-Veiga, Francisco, Macías, Víctor, Fumadó, Lluís, Jové, Josep, Mira, Moisés, Villafranca, Elena, Morote, Juan, Celma, Ana, Samper, Pilar, Glaría, Luís A., Cabeza, M<ce:sup loc='post">a</ce:sup>Ángeles, Juan, Germán, Méndez Ramírez, Samuel, Palacios, Amalia, Béjar, Amelia, Garcia, Sonia, Sabater, Sebastà, Pijoan, José Ignacio, and Litwin, Mark S.

Published
2021
Full Text
View/download PDF

6. Follow-up care of 12 months of patients with bladder cancer in Spain: A multicenter prospective cohort study

Author

Bonfill, Xavier, primary, Martinez-Zapata, María José, additional, Barrionuevo-Rosas, Leslie, additional, Vernooij, Robin WM, additional, Sánchez, María José, additional, Morales-Suárez-Varela, María, additional, De la Cruz, Javier, additional, Emparanza, José Ignacio, additional, Ferrer, Montserrat, additional, Pijoan, José Ignacio, additional, Palou, Joan, additional, Frances, Albert, additional, Madrid, Eva, additional, Coscia, Claudia, additional, and Zamora, Javier, additional

Published
2022
Full Text
View/download PDF

8. Stability of SARS-CoV-2 spike antigens against mutations

Author

European Commission, Natural Sciences and Engineering Research Council of Canada, Eusko Jaurlaritza, Universidad del País Vasco, De la Fuente, Ildefonso M. [0000-0001-6548-7583], Malaina, Iker [0000-0002-1305-6623], Carrasco-Pujante, J. [0000-0001-6490-738X], De la Fuente, Ildefonso M., Malaina, Iker, Fedetz, María, Chruszcz, Maksymilian, Grandes, Gontzal, Lozano-Pérez, Antonio A., Shteyer, Eyal, Ya'akov, Ami Ben, Gómez de la Cámara, Agustín, Borobia, Alberto M., Carrasco-Pujante, J., Pijoan, José Ignacio, Bringas, Carlos, Pérez-Yarza, G., Ouro, Alberto, Crawford, Michael J., Shoshan-Barmatz, Varda, Zhurov, Vladimir, López, Jose I., Knafo, Shira, Tary-Lehmann, Magdalena, Gabaldón, Toni, Grbić, Miodrag, European Commission, Natural Sciences and Engineering Research Council of Canada, Eusko Jaurlaritza, Universidad del País Vasco, De la Fuente, Ildefonso M. [0000-0001-6548-7583], Malaina, Iker [0000-0002-1305-6623], Carrasco-Pujante, J. [0000-0001-6490-738X], De la Fuente, Ildefonso M., Malaina, Iker, Fedetz, María, Chruszcz, Maksymilian, Grandes, Gontzal, Lozano-Pérez, Antonio A., Shteyer, Eyal, Ya'akov, Ami Ben, Gómez de la Cámara, Agustín, Borobia, Alberto M., Carrasco-Pujante, J., Pijoan, José Ignacio, Bringas, Carlos, Pérez-Yarza, G., Ouro, Alberto, Crawford, Michael J., Shoshan-Barmatz, Varda, Zhurov, Vladimir, López, Jose I., Knafo, Shira, Tary-Lehmann, Magdalena, Gabaldón, Toni, and Grbić, Miodrag

Abstract

Modern health care needs preventive vaccines and therapeutic treatments with stability against pathogen mutations to cope with current and future viral infections. At the beginning of the COVID-19 pandemic, our analytic and predictive tool identified a set of eight short SARS-CoV-2 S-spike protein epitopes that had the potential to persistently avoid mutation. Here a combination of genetic, Systems Biology and protein structure analyses confirm the stability of our identified epitopes against viral mutations. Remarkably, this research spans the whole period of the pandemic, during which 93.9% of the eight peptides remained invariable in the globally predominant 43 circulating variants, including Omicron. Likewise, the selected epitopes are conserved in 97% of all 1,514 known SARS-CoV-2 lineages. Finally, experimental analyses performed with these short peptides showed their specific immunoreactivity. This work opens a new perspective on the design of next-generation vaccines and antibody therapies that will remain reliable against future pathogen mutations.

Published
2022

10. Mapping the Patient-Oriented Prostate Utility Scale From the Expanded Prostate Cancer Index Composite and the Short-Form Health Surveys

Author

Zamora, Víctor, primary, Garin, Olatz, additional, Pardo, Yolanda, additional, Pont, Àngels, additional, Gutiérrez, Cristina, additional, Cabrera, Patricia, additional, Gómez-Veiga, Francisco, additional, Pijoan, José Ignacio, additional, Litwin, Mark S., additional, Ferrer, Montse, additional, Zamora, Víctor, additional, Ventura, Montse, additional, Guedea, Ferran, additional, Ferrer, Ferran, additional, Boladeras, Ana, additional, Slocker, Andrea, additional, Suárez, José Francisco, additional, Castells, Manuel, additional, Bonet, Xavier, additional, Delgado, David B., additional, Ortiz, MaJosé, additional, Herruzo, Ismael, additional, López-Torrecilla, José, additional, Pastor, Jorge, additional, Muñoz, Víctor, additional, Willsich, Patricia, additional, Vázquez, Marisa, additional, Roselló, Àlvar, additional, Eraso, Arantxa, additional, Ferrer, Carlos, additional, Sánchez, Ángel, additional, Macías, Víctor, additional, Fumadó, Lluís, additional, Jové, Josep, additional, Mira, Moisés, additional, Villafranca, Elena, additional, Morote, Juan, additional, Celma, Ana, additional, Samper, Pilar, additional, Glaría, Luís A., additional, Cabeza, MaÁngeles, additional, Juan, Germán, additional, Méndez Ramírez, Samuel, additional, Palacios, Amalia, additional, Béjar, Amelia, additional, Garcia, Sonia, additional, and Sabater, Sebastà, additional

Published
2021
Full Text
View/download PDF

15. Clinical interval and diagnostic characteristics in a cohort of bladder cancer patients in Spain: a multicenter observational study.

Author

Bonfill, Xavier, Martinez-Zapata, María José, Vernooij, Robin W. M., Sánchez, María José, Suárez-Varela, María Morales, De la Cruz, Javier, Emparanza, José Ignacio, Ferrer, Montserrat, Pijoan, José Ignacio, Palou, Joan, Schmidt, Stefanie, Madrid, Eva, Abraira, Víctor, and Zamora, Javier

Subjects
BLADDER cancer patients, BLADDER cancer diagnosis, CLINICAL trials, BLADDER cancer prevention, BLADDER cancer treatment
Abstract

Objective: We performed a cohort study in seven hospitals in Spain to determine the clinical characteristics of incident patients with bladder cancer, the diagnostic process, and the conditions that might affect health care interval times. Results: 314 patients with bladder cancer were included, 70.3 (Standard Deviation [SD] 11.2) years old and 85.0% male. Clinical stage was T1 in 45.9% of patients. The median interval time between first consultation and diagnosis was of 104.0 days (Inter quartile range [IQR]:112.0; range from 0 to 986), being shorter for those patients who attended a hospital for their first consultation. The median interval time between diagnosis and first treatment was of 0.0 days (IQR: 0.0; range from 0 to 366), being longer when the patient had a pathologic tumor stage ≥ T2a. [ABSTRACT FROM AUTHOR]

Published
2017
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results